Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Liu, L; Salnikov, AV; Bauer, N; Aleksandrowicz, E; Labsch, S; Nwaeburu, C; Mattern, J; Gladkich, J; Schemmer, P; Werner, J; Herr, I.
Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
Int J Cancer. 2014; 134(10):2489-2503 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Autor/innen der Med Uni Graz:
Schemmer Peter

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Number of Figures: 8
| | | | | | | |
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies characterized by an intense tumor stroma with hypoperfused regions, a significant inflammatory response and pronounced therapy resistance. New therapeutic agents are urgently needed. The plant-derived agent triptolide also known as "thunder god vine" has a long history in traditional Chinese medicine for treatment of rheumatoid arthritis and cancer and is now in a clinical phase II trial for establishing the efficacy against a placebo. The authors mimicked the situation in patient tumors by induction of hypoxia in experimental models of pancreatic cancer stem cells (CSCs) and evaluated the therapeutic effect of triptolide. Hypoxia led to induction of colony and spheroid formation, aldehyde dehydrogenase 1 (ALDH1) and NF-κB activity, migratory potential and a switch in morphology to a fibroblastoid phenotype, as well as stem cell- and epithelial-mesenchymal transition-associated protein expression. Triptolide efficiently inhibited hypoxia-induced transcriptional signaling and downregulated epithelial-mesenchymal transition (EMT) and CSC features in established highly malignant cell lines, whereas sensitive cancer cells or nonmalignant cells were less affected. In vivo triptolide inhibited tumor take and tumor growth. In primary CSCs isolated from patient tumors, triptolide downregulated markers of CSCs, proliferation and mesenchymal cells along with upregulation of markers for apoptosis and epithelial cells. This study is the first to show that triptolide reverses EMT and CSC characteristics and therefore may be superior to current chemotherapeutics for treatment of PDA.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Antineoplastic Agents, Alkylating - pharmacology
Biomarkers, Tumor - metabolism
Blotting, Western -
Carcinoma, Pancreatic Ductal - genetics
Carcinoma, Pancreatic Ductal - metabolism
Carcinoma, Pancreatic Ductal - prevention & control
Cell Hypoxia -
Cell Line, Tumor -
Cell Movement - drug effects
Chick Embryo -
Diterpenes - pharmacology
Down-Regulation - drug effects
Epithelial-Mesenchymal Transition - drug effects
Epoxy Compounds - pharmacology
Humans -
Isoenzymes - metabolism
Mice -
Mice, Inbred Strains -
Mice, Nude -
NF-kappa B - genetics
NF-kappa B - metabolism
Neoplastic Stem Cells - drug effects
Neoplastic Stem Cells - metabolism
Neoplastic Stem Cells - pathology
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - prevention & control
Phenanthrenes - pharmacology
Proto-Oncogene Proteins c-rel - genetics
Proto-Oncogene Proteins c-rel - metabolism
RNA Interference -
Retinal Dehydrogenase - metabolism
Spheroids, Cellular - drug effects
Spheroids, Cellular - metabolism
Spheroids, Cellular - pathology
Xenograft Model Antitumor Assays -

Find related publications in this database (Keywords)
pancreatic cancer
novel antitumor agents
epithelial-mesenchymal transition
cancer stem cells
© Med Uni Graz Impressum